EZH2 and glioblastoma: In vitro cytotoxicity studies were carried out to validatewhether the hypothesis of extracting anti-GBM effects via balanceddual modulation of EZH2 and HSP90 corroborates with the experimentalresults (Table 6, Figure 6).